Cargando…
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
We have used FRET-based biosensors in live cells, in a robust high-throughput screening (HTS) platform, to identify small-molecules that alter the structure and activity of the cardiac sarco/endoplasmic reticulum calcium ATPase (SERCA2a). Our primary aim is to discover drug-like small-molecule activ...
Autores principales: | Roopnarine, Osha, Yuen, Samantha L., Thompson, Andrew R., Roelike, Lauren N., Rebbeck, Robyn T., Bidwell, Phillip A., Aldrich, Courtney C., Cornea, Razvan L., Thomas, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002828/ https://www.ncbi.nlm.nih.gov/pubmed/36909610 http://dx.doi.org/10.21203/rs.3.rs-2596384/v1 |
Ejemplares similares
-
Fluorescence lifetime FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
por: Roopnarine, Osha, et al.
Publicado: (2023) -
A Large-Scale High-Throughput Screen for Modulators of SERCA Activity
por: Bidwell, Philip A., et al.
Publicado: (2022) -
RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca(2+) assays
por: Rebbeck, Robyn T., et al.
Publicado: (2020) -
Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca(2+) and phosphorylation
por: Weber, Daniel K, et al.
Publicado: (2021) -
The transmembrane peptide DWORF activates SERCA2a via dual mechanisms
por: Li, Ang, et al.
Publicado: (2021)